Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. Acta Pharmacol Sin 2008 Jul;29(7):781-8
Date
06/21/2008Pubmed ID
18565275Pubmed Central ID
PMC4535343DOI
10.1111/j.1745-7254.2008.00817.xScopus ID
2-s2.0-65849233445 (requires institutional sign-in at Scopus site) 68 CitationsAbstract
AIM: Drug addiction is a chronic brain disease with constant relapse requiring long-term treatment. New pharmacological strategies focus on the development of an effective antirelapse drug. This study examines the effects of levotetrahydropalmatine (l-THP) on reducing heroin craving and increasing the abstinence rate among heroin-dependent patients.
METHODS: In total, 120 heroin-dependent patients participated in the randomized, double-blinded, and placebocontrolled study using l-THP treatment. The participants remained in a ward during a 4-week period of l-THP treatment, followed by 4 weeks of observation after treatment. The patients were followed for 3 months after discharge. Outcome measures are the measured severity of the protracted abstinence withdrawal syndrome (PAWS) and the abstinence rate.
RESULTS: Four weeks of l-THP treatment significantly ameliorated the severity of PAWS, specifically, somatic syndrome, mood states, insomnia, and drug craving, in comparison to the placebo group. Based on the 3 month follow-up observation, participants who survived the initial 2 weeks of l-THP medication and remained in the trial program had a significantly higher abstinence rate of 47.8% (95% confidence interval [CI]: 33%- 67%) than the 15.2% in the placebo group (95% CI: 7%-25%), according to a log- rank test (P<0.0005).
CONCLUSION: l-THP significantly ameliorated PAWS, especially reducing drug craving. Furthermore, it increased the abstinence rate among heroin users. These results support the potential use of l-THP for the treatment of heroin addiction.
Author List
Yang Z, Shao YC, Li SJ, Qi JL, Zhang MJ, Hao W, Jin GZMESH terms used to index this publication - Major topics in bold
AdultAnalgesics, Non-Narcotic
Berberine Alkaloids
Double-Blind Method
Endpoint Determination
Female
Heroin Dependence
Humans
Male
Patient Dropouts
Pilot Projects
Secondary Prevention
Treatment Outcome